Commentary by Danise Schiliro-Chuang MD, NYU Chief Resident
While most of us were enjoying way too much turkey this week, some interesting activity in the world of pharmaceuticals was taking place. Let’s take a …
Commentary by Danise Schiliro-Chuang MD, NYU Chief Resident
While most of us were enjoying way too much turkey this week, some interesting activity in the world of pharmaceuticals was taking place. Let’s take a …
Clinical Correlations will be closed for the holiday and will resume posting on Monday 11/26/07. Have a very happy Thanksgiving and remember, be careful with that turkey…
Case Presentation by Shrujal Baxi MD, Chief Resident
Please review the posting of last week’s CPC here.
When you’re ready you can download the CPC Answer.
Commentary by Jonathan Willner MD, PGY-2
This week’s Medicine Grand Rounds speaker was Lisa Carey, MD, Associate Professor in Hematology/Oncology at the University of North Carolina and Medical Director of the …
Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
As winter quickly approaches and we plunge into flu season, it’s fitting that news of a “killer” cold virus broke last week. According …
Commentary by Jatin Roper MD PGY-3 and Christine Ren MD Associate Professor, Department of Surgery
Bariatric procedures to treat obesity involve the restriction of the gastric reservoir, bypass of part of the gastrointestinal …
Commentary by Helen Kourlas PharmD, Pharmacology Section Editor
On October 16th the FDA announced the approval of raltegravir (Isentress®) for the treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents. …
Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
Published early online in NEJM comes the CORONA study “Rosuvastatin in Older Patients with Systolic Heart Failure”. In this …